Dirk Schrijvers - Concepedia

Author

Dirk Schrijvers

Also Known As

D. Schrijvers, D.L. Schrijvers, D.L.A.L. Schrijvers, Dirk L. A. L. Schrijvers, Dirk L. Schrijvers, Dirk Schrijvers, Manuela Schmidinger, Schrijvers, Dirk

149

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

ZNA Middelheim Hospital Antwerp University Hospital KU Leuven AZ Sint-Lucas Ziekenhuisnetwerk Antwerpen Stuivenberg

About

Dirk Schrijvers is an author at ZNA Middelheim Hospital specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	1.9K
2	Public Health	3	3	75
3	Health Sciences	2	2	32
4	Education	1	1	41
5	Nursing	1	1	25

Dirk Schrijvers

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, New England Journal of Medicine	2012	2.8K
The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients Heinz Ludwig, Simon Van Belle, Peter Barrett‐Lee, European Journal of Cancer Cancer EpidemiologyMedicineCancer ManagementEpidemiology Of CancerCancer Registration	2004	912
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer Kenneth J. Pienta, Jean-Pascal Machiels, Dirk Schrijvers, Investigational New Drugs Cnto 888MedicineHuman Monoclonal AntibodyImmunologyImmune Checkpoint Inhibitor	2012	389
<i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer Bram De Laere, Steffi Oeyen, Markus Mayrhofer, Clinical Cancer Research	2018	161
Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer Abdelbari Baitar, Frank Van Fraeyenhove, A. Vandebroek, Journal of Geriatric Oncology Geriatric OncologyAgingScreening ToolsGeriatricsLongevity	2012	133
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis Markus Mayrhofer, Bram De Laere, Tom Whitington, Genome Medicine	2018	128
Management of Anemia in Cancer Patients: Transfusions Dirk Schrijvers The Oncologist	2011	78
Management of Cancer-Related Anemia in Patients with Breast or Gynecologic Cancer: New Insights Based on Results from the European Cancer Anemia Survey Peter Barrett‐Lee, Carsten Bokemeyer, Pere Gascón, The Oncologist AnemiaBreast OncologyCancer-related AnemiaCancer EpidemiologyMedicine	2005	70
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park, Annals of Oncology Metastatic Urothelial CancerUrologyGenitourinary CancerSelect Fgfr AlterationsMedicine	2023	69
Independent Risk Factors for Anemia in Cancer Patients Receiving Chemotherapy: Results from the European Cancer Anaemia Survey Peter Barrett‐Lee, Heinz Ludwig, Gunnar Birgegård, Oncology	2006	67

Page 1